Page last updated: 2024-08-26

terameprocol and Leukemia

terameprocol has been researched along with Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bassett, D; Beaudry, C; Bogenberger, JM; Carpten, J; Frazer, N; Garcia, R; Hagelstrom, RT; Kim, S; Lekakis, L; McDonagh, KT; Mohrland, S; Schroeder, K; Shanmugam, V; Shea, TC; Tibes, R; Von Hoff, D	1

Trials

1 trial(s) available for terameprocol and Leukemia

Article	Year
Phase I study of the novel Cdc2/CDK1 and AKT inhibitor terameprocol in patients with advanced leukemias. Investigational new drugs, 2015, Volume: 33, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; CDC2 Protein Kinase; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Leukemia; Liver Function Tests; Male; Masoprocol; Maximum Tolerated Dose; Middle Aged; Polyethylene Glycols; Remission Induction	2015

Article

Year

Phase I study of the novel Cdc2/CDK1 and AKT inhibitor terameprocol in patients with advanced leukemias.

Investigational new drugs, 2015, Volume: 33, Issue:2

Topics: Adult; Aged; Antineoplastic Agents; CDC2 Protein Kinase; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Leukemia; Liver Function Tests; Male; Masoprocol; Maximum Tolerated Dose; Middle Aged; Polyethylene Glycols; Remission Induction

2015